Steroid control of central neuronal interactions and function

• Published in: The Journal of steroid biochemistry and molecular biology Vol. 40; no. 1; pp. 123 - 132
• Main Authors: Fink, George, Rosie, Roberta, Sheward, W.John, Thomson, Elspeth, Wilson, Helen
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 1991
• Subjects: Adrenocorticotropic Hormone - metabolism; Animals; Central Nervous System - physiology; Estrogens - physiology; Female; Gonadotropins - physiology; Hypothalamus - physiology; Prolactin - physiology; Rats; Steroids - physiology
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/0960-0760(91)90175-5

Steroids have potent actions on the brain which can be categorized as; (i) fast (∼ms-s), (ii) intermediate (h-days), (iii) long-term reversible (days-weeks) and (iv) long-term irreversible. Here attention is focussed on the intermediate and long-term reversible effects of steroids with emphasis on glucocorticoids and oestrogen. Glucocorticoid negative feedback is generally classified as fast, delayed and long-term. Fast negative feedback would appear to depend mainly on a reduction in pituitary responsiveness to corticotrophin releasing factor-41 (CRF-41) and possibly arginine vasopressin (AVP). Delayed feedback is mediated by reduced AVP release into hypophysial portal blood and blockade of the ACTH response to CRF-41. Long-term negative feedback is a consequence of reduced CRF-41 and AVP release into portal blood. Lesion and electrical stimulation studies pinpoint the paraventricular nuclei as the main site at which glucocorticoids act to control ACTH release. Oestrogen at physiologically low plasma concentrations inhibits gonadotrophin secretion. At physiologically high plasma concentrations, such as those that occur during the preovulatory surge, oestradiol-17β stimulates the biosynthesis of LHRH mRNA and LHRH and the release of LHRH into hypophysial portal blood. Oestradiol also increases pituitary responsiveness to LHRH. The action of oestrogen on LHRH neurons is probably mediated by interneurons and may involve disinhibition; this view is supported by our in situ hybridization studies which show that oestrogen, in its positive feedback mode, significantly reduces the synthesis of proopiomelanocortin mRNA in arcuate neurons which when active are likely to inhibit LHRH neurons. The mechanism of action of oestrogen on the pituitary gland is not yet established, but clues from the action of the priming effect of LHRH suggests that oestrogen may potentiate phosphoinositide second messenger cascades. LHRH priming involves the synthesis of a 70 kDa protein the N-terminus of which is identical to an oestrogen-induced protein in the ventromedial hypothalamic nucleus involved in lordosis, and to that of phospholipase Cα. Attention is drawn to the remarkable economy of the system by which a single steroid, oestrogen, has effects on the brain and pituitary gland which result in a co-ordinated sequence of amplifier cascades which lead first to the ovulatory surge of luteinizing hormone and then to mating behaviour, both of which are obviously essential for continuation of the species. Long-term reversible effects of steroids are exemplified by (i) the action of testosterone, and its metabolite, oestrogen, in stimulating the synthesis of AVP in neurons of the bed nucleus of the stria terminalis, and (ii) the action of oestrogen in reducing by four-fold the amount of the steroid anaesthetic, alphaxalone, required to induce anaesthesia in the male. These stimulatory and inhibitory actions of glucocorticoids and gonadal steroids on the brain and pituitary gland provide excellent models by means of which the molecular mechanisms of central neurotransmission in mammalian brain can be established.